Literaturverzeichnis

[1] Gust, I. D.; Burrell, C. J.; Coulepis, A. G.; Robinson, W. S. und Zuckerman, A. J. (1986): Taxonomic classification of human hepatitis B virus, Intervirology 25, Seite 14-29.

[2] Heermann, K. H.; Kruse, F.; Seifer, M. und Gerlich, W. H. (1987): Immunogenicity of the gene S and Pre-S domains in hepatitis B virions and HBsAg filaments, Intervirology 28 [1], Seite 14-25. URL: PM:2448264

[3] Seeger, C. und Mason, W. S. (2000): Hepatitis B Virus Biology, Microbiol Mol Biol Rev 64 [1], Seite 51-68.

[4] Preikschat, P. (2000): Charakterisierung von Hepatitis B-Virus-Populationen in langzeit-immunsupprimierten Virusträgern im Verlauf der chronischen Hepatitis unter besonderer Berücksichtigung der Rolle der Core-Deletionsvarianten, Dissertation, Humboldt-Universität Berlin.

[5] Moolla, Naazneen; Kew, Michael und Arbuthnot, Patrick (2002): Regulatory elements of hepatitis B virus transcription, J Viral Hepat 9 [5], Seite 323-331. URL: http://www.blackwell-synergy.com/links/doi/10.1046/j.1365-2893.2002.00381.x/abs

[6] Kramvis, A.; Kew, M. und Francois, G. (2005): Hepatitis B virus genotypes, Vaccine 23 [19], Seite 2409-2423. URL: PM:15752827

[7] Gerlich, W. H.; Lu, X. und Heermann, K. H. (1993): Studies on the attachment and penetration of hepatitis B virus, J.Hepatol. 17 Suppl 3, Seite S10-S14.

[8] Sominskaya, I.; Pushko, P.; Dreilina, D.; Kozlovskaya, T. und Pumpen, P. (1992): Determination of the minimal length of preS1 epitope recognized by a monoclonal antibody which inhibits attachment of hepatitis B virus to hepatocytes, Med.Microbiol.Immunol.Berl. 181, Seite 215-226.

[9] Le Seyec, J.; Chouteau, P.; Cannie, I.; Guguen Guillouzo, C. und Gripon, P. (1999): Infection process of the hepatitis B virus depends on the presence of a defined sequence in the pre-S1 domain, J Virol 73, Seite 2052-2057.

[10] Urban, S.; Schwarz, C.; Marx, U. C.; Zentgraf, H.; Schaller, H. und Multhaup, G. (2000): Receptor recognition by a hepatitis B virus reveals a novel mode of high affinity virus-receptor interaction, EMBO J 19 [6], Seite 1217-1227.

[11] Paran, N.; Geiger, B. und Shaul, Y. (2001): HBV infection of cell culture: evidence for multivalent and cooperative attachment, EMBO J 20 [16], Seite 4443-4453.

[12] Gripon, P.; Cannie, I. und Urban, S. (2005): Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein, Journal of Virology 79 [3], Seite 1613-1622. URL: PM:15650187

[13] GLEBE, D.; Urban, S.; Knoop, E. V.; Cag, N.; Krass, P.; Grun, S.; Bulavaite, A.; Sasnauskas, K. und Gerlich, W. H. (2005): Mapping of the hepatitis B virus attachment site by use of infection-inhibiting preS1 lipopeptides and tupaia hepatocytes, Gastroenterology 129 [1], Seite 234-245. URL: PM:16012950

[14] Rabe, B.; Vlachou, A.; Pante, N.; Helenius, A. und Kann, M. (2003): Nuclear import of hepatitis B virus capsids and release of the viral genome, Proc.Natl.Acad.Sci.U.S.A 100 [17], Seite 9849-9854. URL: PM:12909718

[15] Günther, S.; Sommer, G.; Iwanska, A. und Will, H. (1997): Heterogeneity and common features of defective hepatitis B virus genomes derived from spliced pregenomic RNA, Virology 238, Seite 363-371.

[16] Hass, M.; Hannoun, C.; Kalinina, T.; Sommer, G.; Manegold, C. und Gunther, S. (2005): Functional analysis of hepatitis B virus reactivating in hepatitis B surface antigen-negative individuals, HEPATOLOGY 42 [1], Seite 93-103. URL: PM:15962285

[17] Hu, J.; Flores, D.; Toft, D.; Wang, X. und Nguyen, D. (2004): Requirement of heat shock protein 90 for human hepatitis B virus reverse transcriptase function, Journal of Virology 78 [23], Seite 13122-13131. URL: PM:15542664

[18] Park, S. G. und Jung, G. (2001): Human hepatitis B virus polymerase interacts with the molecular chaperonin Hsp60, J Virol 75 [15], Seite 6962-6968.

[19] Junker Niepmann, M.; Bartenschlager, R. und Schaller, H. (1990): A short cis-acting sequence is required for hepatitis B virus pregenome encapsidation and sufficient for packaging of foreign RNA, EMBO J. 9, Seite 3389-3396.

[20] Pollack, J. R. und Ganem, D. (1994): Site-specific RNA binding by a hepatitis B virus reverse transcriptase initiates two distinct reactions: RNA packaging and DNA synthesis, J Virol 68, Seite 5579-5587.

[21] Bartenschlager, R. und Schaller, H. (1992): Hepadnaviral assembly is initiated by polymerase binding to the encapsidation signal in the viral RNA genome, EMBO J 11, Seite 3413-3420.

[22] Bartenschlager, R.; Junker Niepmann, M. und Schaller, H. (1990): The P gene product of hepatitis B virus is required as a structural component for genomic RNA encapsidation, Journal of Virology 64, Seite 5324-5332.

[23] Nassal, M. (1999): Hepatitis B virus replication: novel roles for virus-host interactions, Intervirology 42 [2-3], Seite 100-116. URL: PM:10516465

[24] Liu, N.; Ji, L.; Maguire, M. L. und Loeb, D. D. (2004): cis-Acting sequences that contribute to the synthesis of relaxed-circular DNA of human hepatitis B virus, Journal of Virology 78 [2], Seite 642-649. URL: PM:14694095

[25] Tang, H. und McLachlan, A. (2002): A pregenomic RNA sequence adjacent to DR1 and complementary to epsilon influences hepatitis B virus replication efficiency, Virology 303 [1], Seite 199-210. URL: PM:12482672

[26] Lee, J.; Shin, M. K.; Lee, H. J.; Yoon, G. und Ryu, W. S. (2004): Three novel cis-acting elements required for efficient plus-strand DNA synthesis of the hepatitis B virus genome, Journal of Virology 78 [14], Seite 7455-7464. URL: PM:15220419

[27] Shin, M. K.; Lee, J. und Ryu, W. S. (2004): A novel cis-acting element facilitates minus-strand DNA synthesis during reverse transcription of the hepatitis B virus genome, Journal of Virology 78 [12], Seite 6252-6262. URL: PM:15163718

[28] Bruss, V. (2004): Envelopment of the hepatitis B virus nucleocapsid, Virus Research 106 [2], Seite 199-209. URL: PM:15567498

[29] Wei, Y.; Tavis, J. E. und Ganem, D. (1996): Relationship between viral DNA synthesis and virion envelopment in hepatitis B viruses, J Virol 70, Seite 6455-6458.

[30] Gerelsaikhan, T.; Tavis, J. E. und Bruss, V. (1996): Hepatitis B virus nucleocapsid envelopment does not occur without genomic DNA synthesis, J Virol 70, Seite 4269-4274.

[31] Lan, Y. T.; Li, J.; Liao, W. und Ou, J. (1999): Roles of the three major phosphorylation sites of hepatitis B virus core protein in viral replication, Virology 259, Seite 342-348.

[32] Gazina, E. V.; Fielding, J. E.; Lin, B. und Anderson, D. A. (2000): Core protein phosphorylation modulates pregenomic RNA encapsidation to different extents in human and duck hepatitis B viruses, Journal of Virology 74 [10], Seite 4721-4728. URL: PM:10775610

[33] Daub, H.; Blencke, S.; Habenberger, P.; Kurtenbach, A.; Dennenmoser, J.; Wissing, J.; Ullrich, A. und Cotten, M. (2002): Identification of SRPK1 and SRPK2 as the major cellular protein kinases phosphorylating hepatitis B virus core protein, Journal of Virology 76 [16], Seite 8124-8137. URL: PM:12134018

[34] Perlman, D. H.; Berg, E. A.; O'connor, P. B.; Costello, C. E. und Hu, J. (2005): Reverse transcription-associated dephosphorylation of hepadnavirus nucleocapsids, Proc.Natl.Acad.Sci.U.S.A 102 [25], Seite 9020-9025. URL: PM:15951426

[35] Bruss, V. (1997): A short linear sequence in the pre-S domain of the large hepatitis B virus envelope protein required for virion formation, Journal of Virology 71, Seite 9350-9357.

[36] Poisson, F.; Severac, A.; Hourioux, C.; Goudeau, A. und Roingeard, P. (1997): Both pre-S1 and S domains of hepatitis B virus envelope proteins interact with the core particle, Virology 228, Seite 115-120.

[37] Tuttleman, J. S.; Pourcel, C. und Summers, J. (1986): Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells, Cell 47 [3], Seite 451-460. URL: PM:3768961

[38] Lenhoff, R. J. und Summers, J. (1994): Coordinate regulation of replication and virus assembly by the large envelope protein of an avian hepadnavirus, Journal of Virology 68, Seite 4565-4571.

[39] Summers, J.; Smith, P. M.; Huang, M. J. und Yu, M. S. (1991): Morphogenetic and regulatory effects of mutations in the envelope proteins of an avian hepadnavirus, Journal of Virology 65 [3], Seite 1310-1317. URL: PM:1995945

[40] Yu, X. und Mertz, J. E. (1996): Promoters for synthesis of the pre-C and pregenomic mRNAs of human hepatitis B virus are genetically distinct and differentially regulated, J Virol 70, Seite 8719-8726.

[41] Yu, X. und Mertz, J. E. (1997): Differential regulation of the pre-C and pregenomic promoters of human hepatitis B virus by members of the nuclear receptor superfamily, Journal of Virology 71 [12], Seite 9366-9374. URL: PM:9371596

[42] Yuh, C. H.; Chang, Y. L. und Ting, L. P. (1992): Transcriptional regulation of precore and pregenomic RNAs of hepatitis B virus, J Virol 66, Seite 4073-4084.

[43] Valenzuela, P.; Quiroga, M.; Zaldivar, J.; Gray, P. und Rutter, W. J. (1980): The nucleotide sequence of the hepatitis B viral genome and the identification of the major viral genes, Fields, B. N.; Jaenisch, R. und Fox, C. F, Animal Virus Genetics , Seite 57-70, Academic Press, New York.

[44] Lo, W. Y. und Ting, L. P. (1994): Repression of enhancer II activity by a negative regulatory element in the hepatitis B virus genome, J Virol 68, Seite 1758-1764.

[45] Chen, M. und Ou, J. H. (1995): Cell type-dependent regulation of the activity of the negative regulatory element of the hepatitis B virus core promoter, Virology 214, Seite 198-206.

[46] Raney, A. K.; Johnson, J. L.; Palmer, C. N. und McLachlan, A. (1997): Members of the nuclear receptor superfamily regulate transcription from the hepatitis B virus nucleocapsid promoter, J Virol 71, Seite 1058-1071.

[47] Zhang, P. und McLachlan, A. (1994): Differentiation-specific transcriptional regulation of the hepatitis B virus nucleocapsid gene in human hepatoma cell lines, Virology 202, Seite 430-440.

[48] Yu, X. und Mertz, J. E. (2003): Distinct modes of regulation of transcription of hepatitis B virus by the nuclear receptors HNF4alpha and COUP-TF1, Journal of Virology 77 [4], Seite 2489-2499. URL: PM:12551987

[49] Lopez Cabrera, M.; Letovsky, J.; Hu, K. Q. und Siddiqui, A. (1990): Multiple liver-specific factors bind to the hepatitis B virus core/pregenomic promoter: trans-activation and repression by CCAAT/enhancer binding protein, .Proc.Natl.Acad.Sci.U.S.A. 87, Seite 5069-5073.

[50] Xu, Z.; Jensen, G. und Yen, T. S. (1997): Activation of hepatitis B virus S promoter by the viral large surface protein via induction of stress in the endoplasmic reticulum, J Virol 71, Seite 7387-7392.

[51] Zhang, P.; Raney, A. K. und McLachlan, A. (1992): Characterization of the hepatitis B virus X- and nucleocapsid gene transcriptional regulatory elements, Virology 191, Seite 31-41.

[52] Takada, S.; Kaneniwa, N.; Tsuchida, N. und Koike, K. (1996): Hepatitis B virus X gene expression is activated by X protein but repressed by p53 tumor suppressor gene product in the transient expression system, Virology 216, Seite 80-89.

[53] Bock, C. T.; Malek, N. P.; Tillmann, H. L.; Manns, M. P. und Trautwein, C. (2000): The enhancer I core region contributes to the replication level of hepatitis B virus In vivo and In vitro, J Virol 74 [5], Seite 2193-2202.

[54] Yuh, C. H. und Ting, L. P. (1991): C/EBP-like proteins binding to the functional box-alpha and box-beta of the second enhancer of hepatitis B virus, Mol.Cell Biol. 11 [10], Seite 5044-5052. URL: PM:1922032

[55] Doitsh, G. und Shaul, Y. (2004): Enhancer I predominance in hepatitis B virus gene expression, Mol.Cell Biol. 24 [4], Seite 1799-1808. URL: PM:14749394

[56] Huang, J. und Liang, T. J. (1993): A novel hepatitis B virus (HBV) genetic element with Rev response element-like properties that is essential for expression of HBV gene products, .Mol.Cell Biol. 13, Seite 7476-7486.

[57] Huang, Z. M. und Yen, T. S. (1995): Role of the hepatitis B virus posttranscriptional regulatory element in export of intronless transcripts, .Mol.Cell Biol. 15, Seite 3864-3869.

[58] Huang, Z. M. und Yen, T. S. (1994): Hepatitis B virus RNA element that facilitates accumulation of surface gene transcripts in the cytoplasm, J Virol 68, Seite 3193-3199.

[59] Huang, Z. M.; Zang, W. Q. und Yen, T. S. (1996): Cellular proteins that bind to the hepatitis B virus posttranscriptional regulatory element, Virology 217, Seite 573-581.

[60] Ehlers, I.; Horke, S.; Reumann, K.; Rang, A.; Grosse, F.; Will, H. und Heise, T. (2004): Functional characterization of the interaction between human La and hepatitis B virus RNA, J.Biol.Chem. 279 [42], Seite 43437-43447. URL: PM:15302879

[61] Heise, T.; Guidotti, L. G. und Chisari, F. V. (2001): Characterization of nuclear RNases that cleave hepatitis B virus RNA near the La protein binding site, Journal of Virology 75 [15], Seite 6874-6883. URL: PM:11435567

[62] Nassal, M. (1992): The arginine-rich domain of the hepatitis B virus core protein is required for pregenome encapsidation and productive viral positive-strand DNA synthesis but not for virus assembly, J Virol 66, Seite 4107-4116.

[63] Zhou, S. und Standring, D. N. (1992): Hepatitis B virus capsid particles are assembled from core- protein dimer precursors, Proc.Natl.Acad.Sci.U.S.A. 89, Seite 10046-10050.

[64] Zheng, J.; Schodel, F. und Peterson, D. L. (1992): The structure of hepadnaviral core antigens. Identification of free thiols and determination of the disulfide bonding pattern, J.Biol.Chem. 267 [13], Seite 9422-9429. URL: PM:1577770

[65] Nassal, M.; Rieger, A. und Steinau, O. (1992): Topological analysis of the hepatitis B virus core particle by cysteine-cysteine cross-linking, J Mol Biol 225, Seite 1013-1025.

[66] Kann, M. und Gerlich, W. H. (1994): Effect of core protein phosphorylation by protein kinase C on encapsidation of RNA within core particles of hepatitis B virus, J Virol 68, Seite 7993-8000.

[67] Kau, J. H. und Ting, L. P. (1998): Phosphorylation of the core protein of hepatitis B virus by a 46- kilodalton serine kinase, J Virol 72, Seite 3796-3803.

[68] Bottcher, B.; Wynne, S. A. und Crowther, R. A. (1997): Determination of the fold of the core protein of hepatitis B virus by electron cryomicroscopy [see comments], Nature 385, Seite 88-91.

[69] Salfeld, J.; Pfaff, E.; Noah, M. und Schaller, H. (1989): Antigenic determinants and functional domains in core antigen and e antigen from hepatitis B virus, Journal of Virology 63, Seite 798-808.

[70] Garcia, P. D.; Ou, J. H.; Rutter, W. J. und Walter, P. (1988): Targeting of the hepatitis B virus precore protein to the endoplasmic reticulum membrane: after signal peptide cleavage translocation can be aborted and the product released into the cytoplasm, J.Cell Biol. 106 [4], Seite 1093-1104. URL: PM:3283145

[71] Takahashi, K.; Machida, A.; Funatsu, G.; Nomura, M.; Usuda, S.; Aoyagi, S.; Tachibana, K.; Miyamoto, H.; Imai, M.; Nakamura, T.; Miyakawa, Y. und Mayumi, M. (1983): Immunochemical structure of hepatitis B e antigen in the serum, J.Immunol. 130, Seite 2903-2907.

[72] Chen, M. T.; Billaud, J. N.; Sallberg, M.; Guidotti, L. G.; Chisari, F. V.; Jones, J.; Hughes, J. und Milich, D. R. (2004): A function of the hepatitis B virus precore protein is to regulate the immune response to the core antigen, Proc.Natl.Acad.Sci.U.S.A 101 [41], Seite 14913-14918. URL: PM:15469922

[73] Milich, D. und Liang, T. J. (2003): Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection, HEPATOLOGY 38 [5], Seite 1075-1086. URL: PM:14578844

[74] Peterson, D. L.; Nath, N. und Gavilanes, F. (1982): Structure of hepatitis B surface antigen. Correlation of subtype with amino acid sequence and location of the carbohydrate moiety, J.Biol.Chem. 257 [17], Seite 10414-10420. URL: PM:7107612

[75] Stibbe, W. und Gerlich, W. H. (1983): Structural relationships between minor and major proteins of hepatitis B surface antigen, Journal of Virology 46 [2], Seite 626-628. URL: PM:6842680

[76] Persing, D. H.; Varmus, H. E. und Ganem, D. (1987): The preS1 protein of hepatitis B virus is acylated at its amino terminus with myristic acid, Journal of Virology 61, Seite 1672-1677.

[77] Eble, B. E.; MacRae, D. R.; Lingappa, V. R. und Ganem, D. (1987): Multiple topogenic sequences determine the transmembrane orientation of the hepatitis B surface antigen, Mol.Cell Biol. 7, Seite 3591-3601.

[78] Fernholz, D.; Galle, P. R.; Stemler, M.; Brunetto, M.; Bonino, F. und Will, H. (1993): Infectious hepatitis B virus variant defective in pre-S2 protein expression in a chronic carrier, Virology 194, Seite 137-148.

[79] Mehta, A.; Lu, X.; Block, T. M.; Blumberg, B. S. und Dwek, R. A. (1997): Hepatitis B virus (HBV) envelope glycoproteins vary drastically in their sensitivity to glycan processing: evidence that alteration of a single N-linked glycosylation site can regulate HBV secretion, .Proc.Natl.Acad.Sci.U.S.A. 94, Seite 1822-1827.

[80] Bruss, V.; Lu, X.; Thomssen, R. und Gerlich, W. H. (1994): Post-translational alterations in transmembrane topology of the hepatitis B virus large envelope protein, EMBO J 13, Seite 2273-2279.

[81] Ostapchuk, P.; Hearing, P. und Ganem, D. (1994): A dramatic shift in the transmembrane topology of a viral envelope glycoprotein accompanies hepatitis B viral morphogenesis, EMBO J. 13, Seite 1048-1057.

[82] Prange, R. und Streeck, R. E. (1995): Novel transmembrane topology of the hepatitis B virus envelope proteins, EMBO J 14, Seite 247-256.

[83] Klingmuller, U. und Schaller, H. (1993): Hepadnavirus infection requires interaction between the viral pre-S domain and a specific hepatocellular receptor, Journal of Virology 67, Seite 7414-7422.

[84] Le Seyec, J.; Chouteau, P.; Cannie, I.; Guguen Guillouzo, C. und Gripon, P. (1998): Role of the pre-S2 domain of the large envelope protein in hepatitis B virus assembly and infectivity, J Virol 72, Seite 5573-5578.

[85] Hildt, E. und Hofschneider, P. H. (1998): The PreS2 activators of the hepatitis B virus: activators of tumour promoter pathways, .Recent.Results.Cancer Res. 154, Seite 315-329.

[86] Hildt, E.; Urban, S.; Lauer, U.; Hofschneider, P. H. und Kekule, A. S. (1993): ER-localization and functional expression of the HBV transactivator MHBst, .Oncogene 8, Seite 3359-3367.

[87] Hildt, E.; Saher, G.; Bruss, V. und Hofschneider, P. H. (1996): The hepatitis B virus large surface protein (LHBs) is a transcriptional activator, Virology 225, Seite 235-239.

[88] Hildt, E.; Munz, B.; Saher, G.; Reifenberg, K. und Hofschneider, P. H. (2002): The PreS2 activator MHBs(t) of hepatitis B virus activates c-raf-1/Erk2 signaling in transgenic mice, EMBO J. 21 [4], Seite 525-535. URL: PM:11847101

[89] Stockl, L.; Berting, A.; Malkowski, B.; Foerste, R.; Hofschneider, P. H. und Hildt, E. (2003): Integrity of c-Raf-1/MEK signal transduction cascade is essential for hepatitis B virus gene expression, ONCOGENE 22 [17], Seite 2604-2610. URL: PM:12730674

[90] Oess, S. und Hildt, E. (2000): Novel cell permeable motif derived from the PreS2-domain of hepatitis-B virus surface antigens, Gene Ther. 7 [9], Seite 750-758. URL: PM:10822301

[91] Radziwill, G.; Tucker, W. und Schaller, H. (1990): Mutational analysis of the hepatitis B virus P gene product: domain structure and RNase H activity, J Virol 64, Seite 613-620.

[92] Bartenschlager, R. und Schaller, H. (1988): The amino-terminal domain of the hepadnaviral P-gene encodes the terminal protein (genome-linked protein) believed to prime reverse transcription, EMBO J 7, Seite 4185-4192.

[93] Bartholomeusz, A.; Tehan, B. G. und Chalmers, D. K. (2004): Comparisons of the HBV and HIV polymerase, and antiviral resistance mutations, Antivir.Ther. 9 [2], Seite 149-160. URL: PM:15134177

[94] Das, K.; Xiong, X.; Yang, H.; Westland, C. E.; Gibbs, C. S.; Sarafianos, S. G. und Arnold, E. (2001): Molecular modeling and biochemical characterization reveal the mechanism of hepatitis B virus polymerase resistance to lamivudine (3TC) and emtricitabine (FTC), Journal of Virology 75 [10], Seite 4771-4779. URL: PM:11312349

[95] Xu, Z.; Yen, T. S.; Wu, L.; Madden, C. R.; Tan, W.; Slagle, B. L. und Ou, J. H. (2002): Enhancement of hepatitis B virus replication by its X protein in transgenic mice, Journal of Virology 76 [5], Seite 2579-2584. URL: PM:11836439

[96] Bouchard, M. J.; Wang, L. H. und Schneider, R. J. (2001): Calcium signaling by HBx protein in hepatitis B virus DNA replication, Science 294 [5550], Seite 2376-2378. URL: PM:11743208

[97] Melegari, M.; Scaglioni, P. P. und Wands, J. R. (1998): Cloning and characterization of a novel hepatitis B virus x binding protein that inhibits viral replication, J Virol 72, Seite 1737-1743.

[98] Melegari, M.; Wolf, S. K. und Schneider, R. J. (2005): Hepatitis B virus DNA replication is coordinated by core protein serine phosphorylation and HBx expression, Journal of Virology 79 [15], Seite 9810-9820. URL: PM:16014942

[99] Leupin, O.; Bontron, S.; Schaeffer, C. und Strubin, M. (2005): Hepatitis B virus X protein stimulates viral genome replication via a DDB1-dependent pathway distinct from that leading to cell death, Journal of Virology 79 [7], Seite 4238-4245. URL: PM:15767425

[100] Murakami, S. (2001): Hepatitis B virus X protein: a multifunctional viral regulator, J Gastroenterol. 36 [10], Seite 651-660. URL: PM:11686474

[101] Bouchard, M. J. und Schneider, R. J. (2004): The enigmatic X gene of hepatitis B virus, Journal of Virology 78 [23], Seite 12725-12734. URL: PM:15542625

[102] Arbuthnot, P.; Capovilla, A. und Kew, M. (2000): Putative role of hepatits B virus X protein in hepatocarcinogenesis: Effects on apoptosis, DNA repair, mitogen-activated protein kinase and JAK/STAT pathways, Journal of Gastroenterology and Hepatology 15, Seite 357-368.

[103] Murakami, S. (1999): Hepatitis B virus X protein: structure, function and biology, Intervirology 42 [2-3], Seite 81-99. URL: PM:10516464

[104] Hu, Z.; Zhang, Z.; Doo, E.; Coux, O.; Goldberg, A. L. und Liang, T. J. (1999): Hepatitis B virus X protein is both a substrate and a potential inhibitor of the proteasome complex, J Virol 73, Seite 7231-7240.

[105] Robinson, W. S. (1994): Molecular events in the pathogenesis of hepadnavirus-associated hepatocellular carcinoma, Annu.Rev.Med. 45, Seite 297-323. URL: PM:8198385

[106] Andrisani, O. M. und Barnabas, S. (1999): The transcriptional function of the hepatitis B virus X protein and its role in hepatocarcinogenesis (Review), Int.J.Oncol. 15, Seite 373-379.

[107] Yen, T. S. (1996): Hepadnaviral X Protein:Review of Recent Progress, J.Biomed.Sci. 3 [1], Seite 20-30. URL: PM:11725079

[108] Runkel, L.; Fischer, M. und Schaller, H. (1993): Two-codon insertion mutations of the HBx define two separate regions necessary for its trans-activation function, Virology 197, Seite 529-536.

[109] Parashar, Misra K.; Mukherji, A. und Kumar, V. (2004): The conserved amino-terminal region (amino acids 1-20) of the hepatitis B virus X protein shows a transrepression function, Virus Res. 105 [2], Seite 157-165. URL: PM:15351489

[110] Murakami, S.; Cheong, J. H. und Kaneko, S. (1994): Human hepatitis virus X gene encodes a regulatory domain that represses transactivation of X protein, J.Biol.Chem. 269 [21], Seite 15118-15123. URL: PM:8195148

[111] de Franchis, R.; Meucci, G.; Vecchi, M.; Tatarella, M.; Colombo, M.; Del Ninno, E.; Rumi, M. G.; Donato, M. F. und Ronchi, G. (1993): The natural history of asymptomatic hepatitis B surface antigen carriers [see comments], .Ann.Intern.Med. 118, Seite 191-194.

[112] Chisari, F. V. und Ferrari, C. (1995): Hepatitis B virus immunopathology, Springer Semin.Immunopathol. 17, Seite 261-281.

[113] Ganem, D. und Prince, A. M. (2004): Hepatitis B virus infection--natural history and clinical consequences, New England Journal of Medicine 350 [11], Seite 1118-1129. URL: PM:15014185

[114] Ferrari, C.; Penna, A.; Bertoletti, A.; Valli, A.; Antoni, A. D.; Giuberti, T.; Cavalli, A.; Petit, M. A. und Fiaccadori, F. (1990): Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection, J.Immunol. 145, Seite 3442-3449.

[115] Guidotti, L. G. und Chisari, F. V. (2000): Cytokine-mediated control of viral infections, Virology 273 [2], Seite 221-227. URL: PM:10915592

[116] Guidotti, L. G. und Chisari, F. V. (1996): To kill or to cure: options in host defense against viral infection, Curr.Opin.Immunol. 8 [4], Seite 478-483. URL: PM:8794011

[117] Guidotti, L. G.; Rochford, R.; Chung, J.; Shapiro, M.; Purcell, R. und Chisari, F. V. (1999): Viral clearance without destruction of infected cells during acute HBV infection, Science 284, Seite 825-829.

[118] Webster, G. J. und Bertoletti, A. (2002): Control or persistence of hepatitis B virus: the critical role of initial host-virus interactions, Immunol.Cell Biol. 80 [1], Seite 101-105. URL: PM:11869367

[119] Webster, G. J.; Reignat, S.; Maini, M. K.; Whalley, S. A.; Ogg, G. S.; King, A.; Brown, D.; Amlot, P. L.; Williams, R.; Vergani, D.; Dusheiko, G. M. und Bertoletti, A. (2000): Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms, HEPATOLOGY 32 [5], Seite 1117-1124. URL: PM:11050064

[120] Maini, M. K.; Boni, C.; Lee, C. K.; Larrubia, J. R.; Reignat, S.; Ogg, G. S.; King, A. S.; Herberg, J.; Gilson, R.; Alisa, A.; Williams, R.; Vergani, D.; Naoumov, N. V.; Ferrari, C. und Bertoletti, A. (2000): The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection, J.Exp.Med. 191 [8], Seite 1269-1280. URL: PM:10770795

[121] Baron, J. L.; Gardiner, L.; Nishimura, S.; Shinkai, K.; Locksley, R. und Ganem, D. (2002): Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection, Immunity. 16 [4], Seite 583-594. URL: PM:11970881

[122] Perrillo, R. P. (2001): Acute flares in chronic hepatitis B: the natural and unnatural history of an immunologically mediated liver disease, Gastroenterology 120 [4], Seite 1009-1022. URL: PM:11231956

[123] Chisari, F. V. und Ferrari, C. (1995): Hepatitis B virus immunopathogenesis, .Annu.Rev.Immunol. 13, Seite 29-60.

[124] Günther, S.; Fischer, L.; Pult, I.; Sterneck, M. und Will, H. (1999): Naturally occurring variants of hepatitis B virus, .Adv.Virus Res. 52, Seite 25-137.

[125] Pol, S.; Samuel, D.; Cadranel, J.; Legendre, C.; Bismuth, H.; Brechot, C. und Kreis, H. (2000): Hepatitis and solid organ transplantation, Transplant.Proc. 32 [2], Seite 454-457. URL: PM:10715478

[126] Lai, M. K. (1998): Viral hepatitis and kidney transplantation, J.Formos.Med.Assoc. 97, Seite 801-811.

[127] Fabrizi, F. und Martin, P. (2000): Hepatitis B virus infection in dialysis patients, Am.J.Nephrol. 20 [1], Seite 1-11. URL: PM:10644861

[128] Kelly, C. J. (1994): T cell function in chronic renal failure and dialysis, Blood Purif. 12 [1], Seite 36-41. URL: PM:7986474

[129] Kohler, H. und Meuer, S. C. (1994): Effects of interleukin-2 on hepatitis B vaccination in uraemic patients, Lancet 344 [8933], Seite 1368-1369. URL: PM:7832889

[130] Gane, E. und Pilmore, H. (2002): Management of chronic viral hepatitis before and after renal transplantation, Transplantation 74 [4], Seite 427-437. URL: PM:12352899

[131] Fairley, C. K.; Mijch, A.; Gust, I. D.; Nichilson, S.; Dimitrakakis, M. und Lucas, C. R. (1991): The increased risk of fatal liver disease in renal transplant patients who are hepatitis Be antigen and/or HBV DNA positive, Transplantation 52, Seite 497-500.

[132] Parfrey, P. S.; Forbes, R. D.; Hutchinson, T. A.; Kenick, S.; Farge, D.; Dauphinee, W. D.; Seely, J. F. und Guttmann, R. D. (1985): The impact of renal transplantation on the course of hepatitis B liver disease, Transplantation 39, Seite 610-615.

[133] Rao, K. V.; Kasiske, B. L. und Anderson, W. R. (1991): Variability in the morphological spectrum and clinical outcome of chronic liver disease in hepatitis B-positive and B-negative renal transplant recipients, Transplantation 51 [2], Seite 391-396. URL: PM:1994533

[134] Preikschat, P.; Günther, S.; Reinhold, S.; Will, H.; Budde, K.; Neumayer, H. H.; Krüger, D. H. und Meisel, H. (2002): Complex hepatitis B virus populations with mutations in core promotor, C gene and pre-S region are associated with development of liver cirrhosis in long-term renal transplant recipients, HEPATOLOGY 35, Seite 466-477.

[135] Tur Kaspa, R.; Shaul, Y.; Moore, D. D.; Burk, R. D.; Okret, S.; Poellinger, L. und Shafritz, D. A. (1988): The glucocorticoid receptor recognizes a specific nucleotide sequence in hepatitis B virus DNA causing increased activity of the HBV enhancer, Virology 167, Seite 630-633.

[136] Chou, C. K.; Wang, L. H.; Lin, H. M. und Chi, C. W. (1992): Glucocorticoid stimulates hepatitis B viral gene expression in cultured human hepatoma cells, HEPATOLOGY 16, Seite 13-18.

[137] Ohtsu, T.; Sai, T.; Oka, M.; Sugai, Y. und Tobinai, K. (1991): Activation of hepatitis B virus infection by chemotherapy containing glucocorticoid in hepatitis B virus carriers with hematologic malignancies, Jpn.J.Clin.Oncol. 21, Seite 360-365.

[138] Kletzmayr, J. und Watschinger, B. (2002): Chronic hepatitis B virus infection in renal transplant recipients, Semin.Nephrol. 22 [4], Seite 375-389. URL: PM:12118403

[139] Lam, P. W.; Wachs, M. E.; Somberg, K. A.; Vincenti, F.; Lake, J. R. und Ferrell, L. D. (1996): Fibrosing cholestatic hepatitis in renal transplant recipients, Transplantation 61, Seite 378-381.

[140] Trautwein, C.; Schrem, H.; Tillmann, H. L.; Kubicka, S.; Walker, D.; Boker, K. H.; Maschek, H. J.; Pichlmayr, R. und Manns, M. P. (1996): Hepatitis B virus mutations in the pre-S genome before and after liver transplantation, HEPATOLOGY 24, Seite 482-488.

[141] Fang, J. W.; Wright, T. L. und Lau, J. Y. (1993): Fibrosing cholestatic hepatitis in patient with HIV and hepatitis B [letter], Lancet 342, Seite 1175-1175.

[142] Davies, S. E.; Portmann, B. C.; O'Grady, J. G.; Aldis, P. M.; Chaggar, K.; Alexander, G. J. und Williams, R. (1991): Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis, Hepatol 13, Seite 150-157.

[143] Foo, N. C.; Ahn, B. Y.; Ma, X.; Hyun, W. und Yen, T. S. (2002): Cellular vacuolization and apoptosis induced by hepatitis B virus large surface protein, HEPATOLOGY 36 [6], Seite 1400-1407.

[144] Zanati, S. A.; Locarnini, S. A.; Dowling, J. P.; Angus, P. W.; Dudley, F. J. und Roberts, S. K. (2004): Hepatic failure due to fibrosing cholestatic hepatitis in a patient with pre-surface mutant hepatitis B virus and mixed connective tissue disease treated with prednisolone and chloroquine, J.Clin.Virol. 31 [1], Seite 53-57. URL: PM:15288614

[145] Liaw, Y. F.; Tai, D. I.; Chu, C. M. und Chen, T. J. (1988): The development of cirrhosis in patients with chronic type B hepatitis: a prospective study, HEPATOLOGY 8 [3], Seite 493-496. URL: PM:3371868

[146] Yang, H. I.; Lu, S. N.; Liaw, Y. F.; You, S. L.; Sun, C. A.; Wang, L. Y.; Hsiao, C. K.; Chen, P. J.; Chen, D. S. und Chen, C. J. (2002): Hepatitis B e antigen and the risk of hepatocellular carcinoma, New England Journal of Medicine 347 [3], Seite 168-174. URL: PM:12124405

[147] Wong, D. K.; Cheung, A. M.; O'Rourke, K.; Naylor, C. D.; Detsky, A. S. und Heathcote, J. (1993): Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A meta-analysis [see comments], .Ann.Intern.Med. 119, Seite 312-323.

[148] Tillmann, H. L.; Bock, C. T.; Bleck, J. S.; Rosenau, J.; Boker, K. H.; Barg-Hock, H.; Becker, T.; Trautwein, C.; Klempnauer, J.; Flemming, P. und Manns, M. P. (2003): Successful treatment of fibrosing cholestatic hepatitis using adefovir dipivoxil in a patient with cirrhosis and renal insufficiency, Liver Transpl. 9 [2], Seite 191-196. URL: PM:12548514

[149] Opio, C. K.; Lee, W. M. und Kirkpatrick, P. (2005): Entecavir, Nat.Rev.Drug Discov. 4 [7], Seite 535-536. URL: PM:16075486

[150] Hannoun, C.; Horal, P. und Lindh, M. (2000): Long-term mutation rates in the hepatitis B virus genome, J Gen Virol 81 Pt 1, Seite 75-83.

[151] Günther, S.; Sommer, G.; Von Breunig, F.; Iwanska, A.; Kalinina, T.; Sterneck, M. und Will, H. (1998): Amplification of full-length hepatitis B virus genomes from samples from patients with low levels of viremia: frequency and functional consequences of PCR-introduced mutations, Journal of Clinical Microbiology 36, Seite 531-538.

[152] Blum, H. E. (1993): Hepatitis B virus: significance of naturally occurring mutants, .Intervirology 35, Seite 40-50.

[153] Burda, M. R.; Günther, S.; Dandri, M.; Will, H. und Petersen, J. (2001): Structural and functional heterogeneity of naturally occurring hepatitis B virus variants, Antiviral Res 52 [2], Seite 125-138. URL: PM:11672822

[154] Okamoto, H.; Wang, Y.; Tanaka, T.; Machida, A.; Miyakawa, Y. und Mayumi, M. (1993): Trans-complementation among naturally occurring deletion mutants of hepatitis B virus and integrated viral DNA for the production of viral particles with mutant genomes in hepatoma cell lines, J Gen Virol 74, Seite 407-414.

[155] Pumpens, P.; Grens, E. und Nassal, M. (2002): Molecular epidemiology and immunology of hepatitis B virus infection - an update, Intervirology 45 [4-6], Seite 218-232. URL: PM:12566704

[156] Pult, I.; Chouard, T.; Wieland, S.; Klemenz, R.; Yaniv, M. und Blum, H. E. (1997): A hepatitis B virus mutant with a new hepatocyte nuclear factor 1 binding site emerging in transplant-transmitted fulminant hepatitis B, HEPATOLOGY 25, Seite 1507-1515.

[157] Günther, S.; Piwon, N.; Iwanska, A.; Schilling, R.; Meisel, H. und Will, H. (1996): Type, prevalence, and significance of core promoter/enhancer II mutations in hepatitis B viruses from immunosuppressed patients with severe liver disease, J Virol 70, Seite 8318-8331.

[158] Schlager, F.; Schaefer, S.; Metzler, M.; Gratzki, N.; Lampert, F.; Gerlich, W. H. und Repp, R. (2000): Quantitative DNA fragment analysis for detecting low amounts of hepatitis B virus deletion mutants in highly viremic carriers [In Process Citation], HEPATOLOGY 32 [5], Seite 1096-1105.

[159] Günther, S.; Baginski, S.; Kissel, H.; Reinke, P.; Kruger, D. H.; Will, H. und Meisel, H. (1996): Accumulation and persistence of hepatitis B virus core gene deletion mutants in renal transplant patients are associated with end-stage liver disease, HEPATOLOGY 24, Seite 751-758.

[160] Kalinina, T.; Riu, A; Fischer, L.; Will, H. und Sterneck, M. (2001): A dominant hepatitis B virus population defective in virus secretion because of several S-gene mutations from a patient with fulminant hepatitis, HEPATOLOGY 34 [(2)], Seite 385-394.

[161] Bock, C. T.; Buerke, B.; Tillmann, H. L.; Tacke, F.; Kliem, V.; Manns, M. P. und Trautwein, C. (2003): Relevance of hepatitis B core gene deletions in patients after kidney transplantation, Gastroenterology 124 [7], Seite 1809-1820. URL: PM:12806615

[162] Marinos, G.; Torre, F.; Gunther, S.; Thomas, M. G.; Will, H.; Williams, R. und Naoumov, N. V. (1996): Hepatitis B virus variants with core gene deletions in the evolution of chronic hepatitis B infection, .Gastroenterology 111, Seite 183-192.

[163] Fiordalisi, G.; Primi, D.; Tanzi, E.; Magni, E.; Incarbone, C.; Zanetti, A. R. und Cariani, E. (1994): Hepatitis B virus C gene heterogeneity in a familial cluster of anti-HBc negative chronic carriers, J Med Virol 42, Seite 109-114.

[164] Zoulim, F.; Zhang, X.; Pichoud, C. und Trepo, C. (1996): Heterogeneity of hepatitis B virus (HBV) core gene in a patient with HBV-associated cirrhosis and serum negativity for anti-HBc, J.Hepatol. 24, Seite 155-160.

[165] Laskus, T.; Rakela, J.; Steers, J. L.; Wiesner, R. H. und Persing, D. H. (1994): Precore and contiguous regions of hepatitis B virus in liver transplantation for end-stage hepatitis B, .Gastroenterology 107, Seite 1774-1780.

[166] Gerolami, R.; Henry, M.; Borentain, P.; Colson, P.; Botta, D. und Tamalet, C. (2005): Fulminant hepatitis B associated with a specific insertion in the basal core promoter region of hepatitis B virus DNA after immunosuppressive treatment, Clin.Infect.Dis. 40 [4], Seite e24-e27. URL: PM:15712066

[167] Repp, R.; Keller, C.; Borkhardt, A.; Csecke, A.; Schaefer, S.; Gerlich, W. H. und Lampert, F. (1992): Detection of a hepatitis B virus variant with a truncated X gene and enhancer II, Archives of Virology 125, Seite 299-304.

[168] Laskus, T.; Rakela, J.; Tong, M. J.; Nowicki, M. J.; Mosley, J. W. und Persing, D. H. (1994): Naturally occurring hepatitis B virus mutants with deletions in the core promoter region, J Hepatol 20, Seite 837-841.

[169] Bock, C. T.; Tillmann, H. L.; Maschek, H. J.; Manns, M. P. und Trautwein, C. (1997): A preS mutation isolated from a patient with chronic hepatitis B infection leads to virus retention and misassembly, Gastroenterology 113, Seite 1976-1982.

[170] Walter, E.; Keist, R.; Niederost, B.; Pult, I. und Blum, H. E. (1996): Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo, HEPATOLOGY 24, Seite 1-5.

[171] Ren, S. und Nassal, M. (2001): Hepatitis B virus (HBV) virion and covalently closed circular DNA formation in primary tupaia hepatocytes and human hepatoma cell lines upon HBV genome transduction with replication-defective adenovirus vectors, Journal of Virology 75 [3], Seite 1104-1116. URL: PM:11152483

[172] Chisari, F. V. (1996): Hepatitis B virus transgenic mice: models of viral immunobiology and pathogenesis, Current Topics of Microbiology Immunology 206, Seite 149-173.

[173] Dandri, M.; Burda, M. R.; Torok, E.; Pollok, J. M.; Iwanska, A.; Sommer, G.; Rogiers, X.; Rogler, C. E.; Gupta, S.; Will, H.; Greten, H. und Petersen, J. (2001): Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus, HEPATOLOGY 33 [4], Seite 981-988. URL: PM:11283864

[174] Brown, J. J.; Parashar, B.; Moshage, H.; Tanaka, K. E.; Engelhardt, D.; Rabbani, E.; Roy-Chowdhury, N. und Roy-Chowdhury, J. (2000): A long-term hepatitis B viremia model generated by transplanting nontumorigenic immortalized human hepatocytes in Rag-2-deficient mice, HEPATOLOGY 31 [1], Seite 173-181. URL: PM:10613743

[175] Ohashi, K.; Marion, P. L.; Nakai, H.; Meuse, L.; Cullen, J. M.; Bordier, B. B.; Schwall, R.; Greenberg, H. B.; Glenn, J. S. und Kay, M. A. (2000): Sustained survival of human hepatocytes in mice: A model for in vivo infection with human hepatitis B and hepatitis delta viruses, Nat Med 6 [3], Seite 327-331.

[176] Ilan, E.; Burakova, T.; Dagan, S.; Nussbaum, O.; Lubin, I.; Eren, R.; Ben Moshe, O.; Arazi, J.; Berr, S.; Neville, L.; Yuen, L.; Mansour, T. S.; Gillard, J.; Eid, A.; Jurim, O.; Shouval, D.; Reisner, Y. und Galun, E. (1999): The hepatitis B virus-trimera mouse: a model for human HBV infection and evaluation of anti-HBV therapeutic agents, HEPATOLOGY 29, Seite 553-562.

[177] Dandri, M.; Burda, M. R.; Zuckerman, D. M.; Wursthorn, K.; Matschl, U.; Pollok, J. M.; Rogiers, X.; Gocht, A.; Kock, J.; Blum, H. E.; von Weizsacker, F. und Petersen, J. (2005): Chronic infection with hepatitis B viruses and antiviral drug evaluation in uPA mice after liver repopulation with tupaia hepatocytes, J.Hepatol. 42 [1], Seite 54-60. URL: PM:15629507

[178] Baumert, T. F.; Yang, C.; Schurmann, P.; Kock, J.; Ziegler, C.; Grullich, C.; Nassal, M.; Liang, T. J.; Blum, H. E. und von Weizsacker, F. (2005): Hepatitis B virus mutations associated with fulminant hepatitis induce apoptosis in primary Tupaia hepatocytes, HEPATOLOGY 41 [2], Seite 247-256. URL: PM:15660384

[179] GLEBE, D.; Aliakbari, M.; Krass, P.; Knoop, E. V.; Valerius, K. P. und Gerlich, W. H. (2003): Pre-s1 antigen-dependent infection of Tupaia hepatocyte cultures with human hepatitis B virus, Journal of Virology 77 [17], Seite 9511-9521. URL: PM:12915565

[180] Kock, J.; Baumert, T. F.; Delaney, W. E.; Blum, H. E. und von Weizsacker, F. (2003): Inhibitory effect of adefovir and lamivudine on the initiation of hepatitis B virus infection in primary tupaia hepatocytes, HEPATOLOGY 38 [6], Seite 1410-1418. URL: PM:14647052

[181] Gripon, P.; Rumin, S.; Urban, S.; Le Seyec, J.; Glaise, D.; Cannie, I.; Guyomard, C.; Lucas, J.; Trepo, C. und Guguen-Guillouzo, C. (2002): Infection of a human hepatoma cell line by hepatitis B virus, Proc.Natl.Acad.Sci.U.S.A 99 [24], Seite 15655-15660. URL: PM:12432097

[182] Günther, S.; Li, B. C.; Miska, S.; Kruger, D. H.; Meisel, H. und Will, H. (1995): A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients, J Virol 69, Seite 5437-5444.

[183] Yuan, T. T.; Lin, M. H.; Qiu, S. M. und Shih, C. (1998): Functional characterization of naturally occurring variants of human hepatitis B virus containing the core internal deletion mutation, J Virol 72, Seite 2168-2176.

[184] Shih, C. H.; Li, L. S.; Roychoudhury, S. und Ho, M. H. (1989): In vitro propagation of human hepatitis B virus in a rat hepatoma cell line, Proc.Natl.Acad.Sci.U.S.A. 86, Seite 6323-6327.

[185] Sprinzl, M. F.; Oberwinkler, H.; Schaller, H. und Protzer, U. (2001): Transfer of hepatitis B virus genome by adenovirus vectors into cultured cells and mice: crossing the species barrier, Journal of Virology 75 [11], Seite 5108-5118. URL: PM:11333892

[186] Delaney, W. E 4th und Isom, H. C. (1998): Hepatitis B virus replication in human HepG2 cells mediated by hepatitis B virus recombinant baculovirus, HEPATOLOGY 28, Seite 1134-1146.

[187] Delaney, W. E 4th; Miller, T. G. und Isom, H. C. (1999): Use of the hepatitis B virus recombinant baculovirus-HepG2 system to study the effects of (-)-beta-2',3'-dideoxy-3'- thiacytidine on replication of hepatitis B virus and accumulation of covalently closed circular DNA, Antimicrob.Agents Chemother. 43, Seite 2017-2026.

[188] Günther, S.; Piwon, N.; Jung, A.; Iwanska, A.; Schmitz, H. und Will, H. (2000): Enhanced replication contributes to enrichment of hepatitis B virus with a deletion in the core gene, Virology 273 [2], Seite 286-299.

[189] Yuan, T. T.; Lin, M. H.; Chen, D. S. und Shih, C. (1998): A defective interference-like phenomenon of human hepatitis B virus in chronic carriers, J Virol 72, Seite 578-584.

[190] Moriyama, K. (1997): Reduced antigen production by hepatitis B virus harbouring nucleotide deletions in the overlapping X gene and precore-core promoter, J Gen Virol 78, Seite 1479-1486.

[191] Chua, P. K.; Wen, Y. M. und Shih, C. (2003): Coexistence of two distinct secretion mutations (P5T and I97L) in hepatitis B virus core produces a wild-type pattern of secretion, Journal of Virology 77 [13], Seite 7673-7676. URL: PM:12805468

[192] Parekh, S.; Zoulim, F.; Ahn, S. H.; Tsai, A.; Li, J.; Kawai, S.; Khan, N.; Trepo, C.; Wands, J. und Tong, S. (2003): Genome replication, virion secretion, and e antigen expression of naturally occurring hepatitis B virus core promoter mutants, Journal of Virology 77 [12], Seite 6601-6612. URL: PM:12767980

[193] Delaney, W. E.; Yang, H.; Westland, C. E.; Das, K.; Arnold, E.; Gibbs, C. S.; Miller, M. D. und Xiong, S. (2003): The hepatitis B virus polymerase mutation rtV173L is selected during lamivudine therapy and enhances viral replication in vitro, Journal of Virology 77 [21], Seite 11833-11841. URL: PM:14557667

[194] Le Pogam, S. und Shih, C. (2002): Influence of a putative intermolecular interaction between core and the pre-S1 domain of the large envelope protein on hepatitis B virus secretion, Journal of Virology 76 [13], Seite 6510-6517. URL: PM:12050364

[195] Wen, Y. M. (2004): Structural and functional analysis of full-length hepatitis B virus genomes in patients: Implications in pathogenesis, J.Gastroenterol.Hepatol. 19 [5], Seite 485-489. URL: PM:15086590

[196] Lin, X.; Ma, Z. M.; Yao, X.; Zhang, Y. P. und Wen, Y. M. (2002): Replication efficiency and sequence analysis of full-length hepatitis B virus isolates from hepatocellular carcinoma tissues, Int.J.Cancer 102 [5], Seite 487-491. URL: PM:12432551

[197] Kajiya, Y.; Hamasaki, K.; Nakata, K.; Nakagawa, Y.; Miyazoe, S.; Takeda, Y.; Ohkubo, K.; Ichikawa, T.; Nakao, K.; Kato, Y. und Eguchi, K. (2002): Full-length sequence and functional analysis of hepatitis B virus genome in a virus carrier: a case report suggesting the impact of pre-S and core promoter mutations on the progression of the disease, J.Viral Hepat. 9 [2], Seite 149-156. URL: PM:11876799

[198] Hasegawa, K.; Huang, J.; Rogers, S. A.; Blum, H. E. und Liang, T. J. (1994): Enhanced replication of a hepatitis B virus mutant associated with an epidemic of fulminant hepatitis, J Virol 68, Seite 1651-1659.

[199] Sterneck, M.; Kalinina, T.; Otto, S.; Gunther, S.; Fischer, L.; Burdelski, M.; Greten, H.; Broelsch, C. E. und Will, H. (1998): Neonatal fulminant hepatitis B: structural and functional analysis of complete hepatitis B virus genomes from mother and infant, J Infect Dis 177, Seite 1378-1381.

[200] Sterneck, M.; Kalinina, T.; Gunther, S.; Fischer, L.; Santantonio, T.; Greten, H. und Will, H. (1998): Functional analysis of HBV genomes from patients with fulminant hepatitis, HEPATOLOGY 28, Seite 1390-1397.

[201] Galibert, F.; Mandart, E.; Fitoussi, F.; Tiollais, P. und Charnay, P. (1979): Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E.coli, Nature 25 [281(5733)], Seite 646-650.

[202] Nassal, M. (1988): Total chemical synthesis of a gene for hepatitis B virus core protein and its functional characterization, Gene 66 [2], Seite 279-294. URL: PM:2901997

[203] Cullen, B. R. und Malim, M. H. (1992): Secreted placental alkaline phosphatase as a eukaryotic reporter gene, Methods Enzymol 216, Seite 362-368.

[204] Heermann, K. H.; Goldmann, U.; Schwartz, W.; Seyffarth, T.; Baumgarten, H. und Gerlich, W. H. (1984): Large surface proteins of hepatitis B virus containing the pre-s sequence, Journal of Virology 52, Seite 396-402.

[205] Meisel, H.; Sominskaya, I.; Pumpens, P.; Pushko, P.; Borisova, G.; Deepen, R.; Lu, X.; Spiller, G. H.; Kruger, D. H.; Grens, E. und et al (1994): Fine mapping and functional characterization of two immuno- dominant regions from the preS2 sequence of hepatitis B virus, .Intervirology 37, Seite 330-339.

[206] Beterams, G. und Nassal, M. (2001): Significant interference with hepatitis B virus replication by a core-nuclease fusion protein, J.Biol.Chem. 276 [12], Seite 8875-8883. URL: PM:11124940

[207] Nakabayashi, H.; Taketa, K.; Miyano, K.; Yamane, T. und Sato, J. (1982): Growth of human hepatoma cells lines with differentiated functions in chemically defined medium, Cancer Res. 42, Seite 3858-3863.

[208] Knowles, B. B.; Howe, C. C. und Aden, D. P. (1980): Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen, Science 209 [4455], Seite 497-499. URL: PM:6248960

[209] Yuan, T. T.; Faruqi, A.; Shih, J. W. und Shih, C. (1995): The mechanism of natural occurrence of two closely linked HBV precore predominant mutations, Virology 211, Seite 144-156.

[210] Southern, E. M. (1975): Detection of specific sequences among DNA fragments separated by gel electrophoresis, J.Mol.Biol. 98 [3], Seite 503-517. URL: PM:1195397

[211] Ronaghi, M. (2001): Pyrosequencing sheds light on DNA sequencing, Genome Res. 11 [1], Seite 3-11. URL: PM:11156611

[212] Uhlmann, K.; Brinckmann, A.; Toliat, M. R.; Ritter, H. und Nurnberg, P. (2002): Evaluation of a potential epigenetic biomarker by quantitative methyl-single nucleotide polymorphism analysis, Electrophoresis 23 [24], Seite 4072-4079. URL: PM:12481262

[213] Chisari, F. V.; Filippi, P.; Buras, J.; McLachlan, A.; Popper, H.; Pinkert, C. A.; Palmiter, R. D. und Brinster, R. L. (1987): Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice, Proc.Natl.Acad.Sci.U.S.A. 84, Seite 6909-6913.

[214] Gilles, P. N.; Guerrette, D. L.; Ulevitch, R. J.; Schreiber, R. D. und Chisari, F. V. (1992): HBsAg retention sensitizes the hepatocyte to injury by physiological concentrations of interferon-gamma, HEPATOLOGY 16, Seite 655-663.

[215] Sommer, G.; van Bommel, F. und Will, H. (2000): Genotype-specific synthesis and secretion of spliced hepatitis B virus genomes in hepatoma cells, Virology 271 [2], Seite 371-381. URL: PM:10860890

[216] Buckwold, V. E.; Xu, Z.; Chen, M.; Yen, T. S. und Ou, J. H. (1996): Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication, Journal of Virology 70, Seite 5845-5851.

[217] Li, J.; Buckwold, V. E.; Hon, M. W. und Ou, J. H. (1999): Mechanism of suppression of hepatitis B virus precore RNA transcription by a frequent double mutation, J Virol 73, Seite 1239-1244.

[218] Moriyama, K.; Okamoto, H.; Tsuda, F. und Mayumi, M. (1996): Reduced precore transcription and enhanced core-pregenome transcription of hepatitis B virus DNA after replacement of the precore-core promoter with sequences associated with e antigen- seronegative persistent infections, Virology 226, Seite 269-280.

[219] Zheng, Y.; Li, J. und Ou, J. H. (2004): Regulation of hepatitis B virus core promoter by transcription factors HNF1 and HNF4 and the viral X protein, Journal of Virology 78 [13], Seite 6908-6914. URL: PM:15194767

[220] Preikschat, P.; Borisova, G.; Borschukova, O.; Dislers, A.; Mezule, G.; Grens, E.; Kruger, D. H.; Pumpens, P. und Meisel, H. (1999): Expression, assembly competence and antigenic properties of hepatitis B virus core gene deletion variants from infected liver cells, J Gen Virol 80, Seite 1777-1788.

[221] Kazaks, A.; Dishlers, A.; Pumpens, P.; Ulrich, R.; Kruger, D. H. und Meisel, H. (2003): Mosaic particles formed by wild-type hepatitis B virus core protein and its deletion variants consist of both homo- and heterodimers, FEBS Lett. 549 [1-3], Seite 157-162. URL: PM:12914943

[222] Preikschat, P.; Kazaks, A.; Dishlers, A.; Pumpens, P.; Kruger, D. H. und Meisel, H. (2000): Interaction of wild-type and naturally occurring deleted variants of hepatitis B virus core polypeptides leads to formation of mosaic particles, FEBS Lett. 478 [1-2], Seite 127-132. URL: PM:10922483

[223] Kwon, J. A. und Rho, H. M. (2002): Hepatitis B viral core protein activates the hepatitis B viral enhancer II/pregenomic promoter through the nuclear factor kappaB binding site, Biochem.Cell Biol. 80 [4], Seite 445-455.

[224] Kawai, K.; Horiike, N.; Michitaka, K. und Onji, M. (2003): The effects of hepatitis B virus core promoter mutations on hepatitis B core antigen distribution in hepatocytes as detected by laser-assisted microdissection, J.Hepatol. 38 [5], Seite 635-641. URL: PM:12713875

[225] Jazayeri, M. S.; Dornan, E. S.; Boner, W.; Fattovich, G.; Hadziyannis, S. und Carman, W. F. (2004): Intracellular distribution of hepatitis B virus core protein expressed in vitro depends on the sequence of the isolate and the serologic pattern, Journal of Infectious Diseases 189 [9], Seite 1634-1645. URL: PM:15116300

[226] Serinoz, E.; Varli, M.; Erden, E.; Cinar, K.; Kansu, A.; Uzunalimoglu, O.; Yurdaydin, C. und Bozkaya, H. (2003): Nuclear localization of hepatitis B core antigen and its relations to liver injury, hepatocyte proliferation, and viral load, J.Clin.Gastroenterol. 36 [3], Seite 269-272. URL: PM:12590241

[227] Brandenburg, B.; Gutzeit, C. und Hildt, E. (2005): Intracellular trafficking of hepatitis B virus nucleocapsids, Abstractband der Jahrestagung der Gesellschaft für Virologie, Seite 154-154.

[228] Rabe, B. und Kann, M. (2005): Analysis of the role of the phosphorylation domain of hepatitis B virus capsids for microtubule-dependent intracellular capsid transport, Abstractband der Jahrestagung der Gesellschaft für Virologie, Seite 438-438.

[229] Roingeard, P.; Romet Lemonne, J. L.; Leturcq, D.; Goudeau, A. und Essex, M. (1990): Hepatitis B virus core antigen (HBc Ag) accumulation in an HBV nonproducer clone of HepG2-transfected cells is associated with cytopathic effect, Virology 179, Seite 113-120.

[230] Raney, A. K.; Le, H. B. und McLachlan, A. (1992): Regulation of transcription from the hepatitis B virus major surface antigen promoter by the Sp1 transcription factor, J Virol 66, Seite 6912-6921.

[231] Bock, C. T.; Tillmann, H. L.; Manns, M. P. und Trautwein, C. (1999): The pre-S region determines the intracellular localization and appearance of hepatitis B virus, HEPATOLOGY 30, Seite 517-525.

[232] Xu, Z. und Yen, T. S. (1996): Intracellular retention of surface protein by a hepatitis B virus mutant that releases virion particles, J Virol 70, Seite 133-140.

[233] Melegari, M.; Scaglioni, P. P. und Wands, J. R. (1997): The small envelope protein is required for secretion of a naturally occurring hepatitis B virus mutant with pre-S1 deleted, J Virol 71, Seite 5449-5454.

[234] Tai, P. C.; Suk, F. M.; Gerlich, W. H.; Neurath, A. R. und Shih, C. (2002): Hypermodification and immune escape of an internally deleted middle-envelope (M) protein of frequent and predominant hepatitis B virus variants, Virology 292 [1], Seite 44-58. URL: PM:11878907

[235] Tang, H.; Raney, A. K. und McLachlan, A. (2001): Replication of the wild type and a natural hepatitis B virus nucleocapsid promoter variant is differentially regulated by nuclear hormone receptors in cell culture, Journal of Virology 75 [19], Seite 8937-8948. URL: PM:11533157

[236] Misra, K. P.; Mukherji, A. und Kumar, V. (2004): The conserved amino-terminal region (amino acids 1-20) of the hepatitis B virus X protein shows a transrepression function, Virus Research 105 [2], Seite 157-165. URL: PM:15351489

[237] Sahu, G. K.; Tai, P. C.; Chatterjee, S. B.; Lin, M. H.; Tennant, B.; Gerin, J. und Shih, C. (2002): Out-of-frame versus in-frame core internal deletion variants of human and woodchuck hepatitis B viruses, Virology 292 [1], Seite 35-43. URL: PM:11878906

[238] Ninomiya, T.; Hayashi, Y.; Saijoh, K.; Ohta, K.; Yoon, S.; Nakabayashi, H.; Tamaoki, T.; Kasuga, M. und Itoh, H. (1996): Expression ratio of hepatocyte nuclear factor-1 to variant hepatocyte nuclear factor-1 in differentiation of hepatocellular carcinoma and hepatoblastoma, J.Hepatol. 25 [4], Seite 445-453. URL: PM:8912143

[239] Suk, F. M.; Lin, M. H.; Newman, M.; Pan, S.; Chen, S. H.; Liu, J. D. und Shih, C. (2002): Replication advantage and host factor-independent phenotypes attributable to a common naturally occurring capsid mutation (I97L) in human hepatitis B virus, Journal of Virology 76 [23], Seite 12069-12077.

[240] Yu, X. und Mertz, J. E. (2001): Critical roles of nuclear receptor response elements in replication of hepatitis B virus, Journal of Virology 75 [23], Seite 11354-11364. URL: PM:11689616

[241] Blum, H. E.; Zhang, Z. S.; Galun, E.; von Weizsacker, F.; Garner, B.; Liang, T. J. und Wands, J. R. (1992): Hepatitis B virus X protein is not central to the viral life cycle in vitro, J Virol 66, Seite 1223-1227.

[242] Tang, H.; Delgermaa, L.; Huang, F.; Oishi, N.; Liu, L.; He, F.; Zhao, L. und Murakami, S. (2005): The Transcriptional Transactivation Function of HBx Protein Is Important for Its Augmentation Role in Hepatitis B Virus Replication, Journal of Virology 79 [9], Seite 5548-5556. URL: PM:15827169

[243] Durantel, D.; Carrouee-Durantel, S.; Werle-Lapostolle, B.; Brunelle, M. N.; Pichoud, C.; Trepo, C. und Zoulim, F. (2004): A new strategy for studying in vitro the drug susceptibility of clinical isolates of human hepatitis B virus, HEPATOLOGY 40 [4], Seite 855-864. URL: PM:15382118

[244] Fouillot, N.; Tlouzeau, S.; Rossignol, J. M. und Jean Jean, O. (1993): Translation of the hepatitis B virus P gene by ribosomal scanning as an alternative to internal initiation, J Virol 67, Seite 4886-4895.

[245] Cao, F. und Tavis, J. E. (2004): Detection and characterization of cytoplasmic hepatitis B virus reverse transcriptase, Journal of General Virology 85 [Pt 11], Seite 3353-3360. URL: PM:15483251

[246] Kalinina, T.; Riu, A.; Fischer, L.; Santantonio, T.; Will, H. und Sterneck, M. (2003): Selection of a secretion-incompetent mutant in the serum of a patient with severe hepatitis B, Gastroenterology 125 [4], Seite 1077-1084. URL: PM:14517791

[247] Possehl, C.; Repp, R.; Heermann, K. H.; Korec, E.; Uy, A. und Gerlich, W. H. (1992): Absence of free core antigen in anti-HBc negative viremic hepatitis B carriers, .Arch.Virol.Suppl. 4, Seite 39-41.

[248] Heise, T.; Sommer, G.; Reumann, K.; Meyer, I.; Will, H. und Schaal, H. (2006): The hepatitis B virus PRE contains a splicing regulatory element, Nucleic Acids Res. 34 [1], Seite 353-363. URL: PM:16410615

[249] Cartegni, L.; Wang, J.; Zhu, Z.; Zhang, M. Q. und Krainer, A. R. (2003): ESEfinder: A web resource to identify exonic splicing enhancers, Nucleic Acids Res. 31 [13], Seite 3568-3571. URL: PM:12824367

[250] Obert, S.; Zachmann Brand, B.; Deindl, E.; Tucker, W.; Bartenschlager, R. und Schaller, H. (1996): A splice hepadnavirus RNA that is essential for virus replication, EMBO J. 15, Seite 2565-2574.

[251] Su, T. S.; Lai, C. J.; Huang, J. L.; Lin, L. H.; Yauk, Y. K.; Chang, C. M.; Lo, S. J. und Han, S. H. (1989): Hepatitis B virus transcript produced by RNA splicing, Journal of Virology 63, Seite 4011-4018.

[252] Stutz, F. und Izaurralde, E. (2003): The interplay of nuclear mRNP assembly, mRNA surveillance and export, Trends Cell Biol. 13 [6], Seite 319-327. URL: PM:12791298

[253] Tange, T. O.; Nott, A. und Moore, M. J. (2004): The ever-increasing complexities of the exon junction complex, Curr.Opin.Cell Biol. 16 [3], Seite 279-284. URL: PM:15145352

[254] Reed, R. (2003): Coupling transcription, splicing and mRNA export, Curr.Opin.Cell Biol. 15 [3], Seite 326-331. URL: PM:12787775

[255] Soussan, P.; Garreau, F.; Zylberberg, H.; Ferray, C.; Brechot, C. und Kremsdorf, D. (2000): In vivo expression of a new hepatitis B virus protein encoded by a spliced RNA, J.Clin.Invest 105 [1], Seite 55-60. URL: PM:10619861

[256] Rosmorduc, O.; Petit, M. A.; Pol, S.; Capel, F.; Bortolotti, F.; Berthelot, P.; Brechot, C. und Kremsdorf, D. (1995): In vivo and in vitro expression of defective hepatitis B virus particles generated by spliced hepatitis B virus RNA, HEPATOLOGY 22, Seite 10-19.

[257] Chisari, F. V.; Klopchin, K.; Moriyama, T.; Pasquinelli, C.; Dunsford, H. A.; Sell, S.; Pinkert, C. A.; Brinster, R. L. und Palmiter, R. D. (1989): Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice, Cell 59, Seite 1145-1156.

[258] Wang, H. C.; Chang, W. T.; Chang, W. W.; Wu, H. C.; Huang, W.; Lei, H. Y.; Lai, M. D.; Fausto, N. und Su, I. J. (2005): Hepatitis B virus pre-S2 mutant upregulates cyclin A expression and induces nodular proliferation of hepatocytes, HEPATOLOGY 41 [4], Seite 761-770. URL: PM:15726643

[259] Wang, H. C.; Wu, H. C.; Chen, C. F.; Fausto, N.; Lei, H. Y. und Su, I. J. (2003): Different types of ground glass hepatocytes in chronic hepatitis B virus infection contain specific pre-S mutants that may induce endoplasmic reticulum stress, Am.J.Pathol. 163 [6], Seite 2441-2449. URL: PM:14633616

[260] Fan, Y. F.; Lu, C. C.; Chang, Y. C.; Chang, T. T.; Lin, P. W.; Lei, H. Y. und Su, I. J. (2000): Identification of a pre-S2 mutant in hepatocytes expressing a novel marginal pattern of surface antigen in advanced diseases of chronic hepatitis B virus infection, J.Gastroenterol.Hepatol. 15 [5], Seite 519-528. URL: PM:10847439

[261] Lenhoff, R. J. und Summers, J. (1994): Construction of avian hepadnavirus variants with enhanced replication and cytopathicity in primary hepatocytes, Journal of Virology 68 [9], Seite 5706-5713. URL: PM:8057452

[262] Vignuzzi, M.; Stone, J. K.; Arnold, J. J.; Cameron, C. E. und Andino, R. (2006): Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population, Nature 439 [7074], Seite 344-348. URL: PM:16327776


© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 4.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am:
14.11.2006